Close Menu

plant genomics

Its developers claim that VirusDetect is the first bioinformatics tool designed to use sRNA sequence to identify DNA and RNA viruses and viroids.

Three studies tapped data for plants from the 1001 Genomes Project collection to explore variant, epigenetic, expression, and speciation patterns in Arabidopsis.

An international team has sequenced the Zostera marina genome to uncover gene gains and losses that helped it in its return to the sea.

CyVerse, the developers believe, better expresses the platform's capacity to provide data management and computation to researchers across multiple scientific disciplines.

Researchers plan to identify the plant's genetic diversity and evolutionary history in order to increase production and nutritional value.

The German startup is building a business around providing bioinformatics analysis services to large agricultural biotechnology companies.

The company, a spinoff from the University of Tübingen and a Max Planck Institute, offers bioinformatics services for high-throughput sequencing data to the plant breeding industry.

The effort brings together gene banks, researchers, plant breeders, and big data experts, all of whom will use genomics to unlock crop diversity.

 

The technology is for gene targeting using endocunleases and homologous recombination, and is the second licensing deal between the parties since April.

The project aims to sequence nine different taxa of cultivated potato and one closely-related wild species to facilitate the production of improved varieties of the crop.

Pages

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.